Skip to main content
. 2017 Feb 25;8(5):793–800. doi: 10.7150/jca.17766

Figure 3.

Figure 3

Survival analysis according to chemotherapy regimens and treatment response. Patients treated with asparaginase-based regimens have significantly superior PFS (A), and a trend for better OS (B); patients who get CR after treatment have significantly better PFS and OS (C, D).